CMV reactivation caused by methylprednisolone therapy for ARDS after esophagectomy

Esophagus

Volumn 9, Issue 3, 2012, Pages 141-146

  Sato, Yusuke ^a   Motoyama, Satoru ^a   Maruyama, Kiyotomi ^b   Yoshino, Key ^a   Sasaki, Tomohiko ^a   Wakita, Akiyuki ^a   Ogawa, Jun ichi ^a  

^a AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Suwa Red Cross Hospital   (Japan)

Author keywords

ARDS; CMV; Esophageal cancer; Methylprednisolone; Steroid therapy

Indexed keywords

CISPLATIN; FLUOROURACIL; GANCICLOVIR; METHYLPREDNISOLONE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC ACCURACY; DRUG DOSE REDUCTION; DRUG DOSE SEQUENCE; DRUG MEGADOSE; DRUG PULSE THERAPY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPHOCYTE COUNT; MALE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; STEROID THERAPY; VIRUS REACTIVATION;

EID: 84871311780     PISSN: 16129059     EISSN: 16129067     Source Type: Journal    
DOI: 10.1007/s10388-012-0316-x     Document Type: Article

References (32)

1. de la Hoz RE, Stephens G, Sherlock C. Diagnosis and treatment approaches of CMV infections in adult patients. J Clin Virol. 2002;25(Suppl 2):S1-12.
2. de Vries JJ, Vossen AC, Kroes AC, van der Zeijst BA. Implementing neonatal screening for congenital cytomegalovirus: addressing the deafness of policy makers. Rev Med Virol. 2011; 21:54-61.
3. Cannon MJ, Hyde TB, Schmid DS. Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection. Rev Med Virol. 2011;21:240-55.
4. Crough T, Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev. 2009;22:76-98.
5. Meduri GU, Annane D, Chrousos GP, Marik PE, Sinclair SE. Activation and regulation of systemic inflammation in ARDSrationale for prolonged glucocorticoid therapy. Chest. 2009;136: 1631-43.
6. Bernard GR, Luce JM, Sprung CL, Rinaldo JE, Tate RM, Sibbald WJ, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med. 1987;317:1565-70.
7. Sprung CL, Caralis PV, Marcial EH, Pierce M, Gelbard MA, Long WM, et al. The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med. 1984;311:1137-43.
8. Weigelt JA, Norcross JF, Borman KR, Snyder WHIII. Early steroid therapy for respiratory failure. Arch Surg. 1985;120: 536-40.
9. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA. Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest. 1987;92:1032-6.
10. Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis. 1988;138:62-8.
11. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354:1671-84.
12. Peter JV, John P, Graham PL, Moran JL, George IA, Bersten A. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ. 2008;336:1006-9.
13. Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, et al. Methylprednisolone infusion in early severe ARDS results of a randomized controlled trial. Chest. 2009;136:e 30.
14. Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest. 2007;131(4): 954-63.
15. Deal EN, Hollands JM, Schramm GE, Micek ST. Role of corticosteroids in the management of acute respiratory distress syndrome. Clin Ther. 2008;30:787-99.
16. Sessler CN, Gay PC. Are corticosteroids useful in late-stage acute respiratory distress syndrome? Respir Care. 2010;55:43-55.
17. Sato Y, Motoyama S, Maruyama K, Okuyama M, Hayashi K, Nakae H, et al. Extravascular lung water measured using single transpulmonary thermodilution reflects perioperative pulmonary edema induced by esophagectomy. Eur Surg Res. 2007;39:7-13.
18. Franchin G, Diamond B. Pulse steroids: how much is enough? Autoimmun Rev. 2006;5:111-3.
19. Parker BJ, Bruce IN. High dose methylprednisolone therapy for the treatment of severe systemic lupus erythematosus. Lupus. 2007;16(6):387-93.
20. Kaneko T, Hirama A, Ueda K, Fujino T, Utsumi K, Iino Y, et al. Methylprednisolone pulse therapy combined with mizoribine following tonsillectomy for immunoglobulin A nephropathy: clinical remission rate, steroid sparing effect, and maintenance of renal function. Clin Exp Nephrol. 2011;15(1):73-8.
21. Tomiyama T, Uchida K, Matsushita M, Ikeura T, Fukui T, Takaoka M, et al. Comparison of steroid pulse therapy and conventional oral steroid therapy as initial treatment for autoimmune pancreatitis. J Gastroenterol. 2011;46:696-704.
22. Abo S, Kitamura M, Hashimoto M, Izumi K, Minamiya Y, Shikama T, et al. Analysis of results of surgery performed over a 20-year period on 500 patients with cancer of the thoracic esophagus. Surg Today. 1996;26:77-82.
23. Motoyama S, Kitamura M, Saito R, Maruyama K, Okuyama M, Ogawa J. Outcome and treatment strategy for mid- and lowerthoracic esophageal cancer recurring locally in the lymph nodes of the neck. World J Surg. 2006;30:191-8.
24. Nakamura E, Kitagawa Y, Ozawa S, Suda K, Ando N, Ueda M, et al. Role of steroid administration to reduce inflammation after thoracotomy in a rat surgical stress model. J Surg Res. 2006;135:364-9.
25. Tsukada K, Miyazaki T, Katoh H, Masuda N, Fukuchi M, Manda R, et al. Effect of perioperative steroid therapy on the postoperative course of patients with oesophageal cancer. Dig Liver Dis. 2006;38:240-4.
26. Yano M, Taniguchi M, Tsujinaka T, Fujiwara Y, Yasuda T, Shiozaki H, et al. Is preoperative methylprednisolone beneficial for patients undergoing esophagectomy? Hepatogastroenterology. 2005;52:481-5.
27. Sato N, Koeda K, Ikeda K, Kimura Y, Aoki K, Iwaya T, et al. Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer. Ann Surg. 2002;236:184-90.
28. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149:818-24.
29. Jain M, Duggal S, Chugh TD. Cytomegalovirus infection in nonimmunosuppressed critically ill patients. J Infect Dev Ctries. 2011;5:571-9.
30. Florescu DF, Kalil AC. Cytomegalovirus infections in nonimmunocompromised and immunocompromised patients in the intensive care unit. Infect Disord Drug Targets. 2011 (Epub ahead of print).
31. Peppercorn A, Serody J, Cairns B. Reactivation of cytomegalovirus infection in critically ill immunocompetent patients. JAMA. 2008;300:2367-8.
32. Limaye AP, Kirby KA, Rubenfeld GD, Leisenring WM, Bulger EM, Neff MJ, et al. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA. 2008;300:413-22.